The latest industry happenings of the past month, all in one place.
Elligo Health Research welcomed Michael Gibertini, PhD to its leadership team as Chief Development Officer.
Premier Research announced the addition of Cassandra Matney, MD, as Senior Medical Director.
Novum Pharmaceutical Research Services announced an expansion of its services in North America with the acquisition of Lambda Therapeutic Research’s Toronto, Canada-based clinic and bioanalytical laboratory.
Cognizant announced that its Shared Investigator Platform has reached a new milestone of over 100,000 user in 84 countries.
4G Clinical was ranked #8 on Fast Company's Second Annual List Of The 100 Best Workplaces for Innovators.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.